Allergen immunotherapy: No evidence of infectious risk.
作者信息
Balekian Diana S, Banerji Aleena, Blumenthal Kimberly G, Camargo Carlos A, Long Aidan A
机构信息
Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass; Harvard Medical School, Boston, Mass.
Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass; Harvard Medical School, Boston, Mass; Department of Emergency Medicine, Massachusetts General Hospital, Boston, Mass.
出版信息
J Allergy Clin Immunol. 2016 Jun;137(6):1887-1888. doi: 10.1016/j.jaci.2016.03.021. Epub 2016 Apr 9.
Abstract
摘要
相似文献
1
Allergen immunotherapy: No evidence of infectious risk.变应原免疫疗法：无感染风险证据。
J Allergy Clin Immunol. 2016 Jun;137(6):1887-1888. doi: 10.1016/j.jaci.2016.03.021. Epub 2016 Apr 9.
2
Immunotherapy: Treating with Fewer Allergens?免疫疗法：用更少的变应原进行治疗？
Otolaryngol Clin North Am. 2017 Dec;50(6):1153-1165. doi: 10.1016/j.otc.2017.08.012. Epub 2017 Sep 28.
3
Efficacy and Safety of Subcutaneous and Sublingual Immunotherapy for Allergic Rhinoconjunctivitis and Asthma.皮下和舌下免疫疗法治疗变应性鼻结膜炎和哮喘的疗效与安全性
Otolaryngol Clin North Am. 2017 Dec;50(6):1111-1119. doi: 10.1016/j.otc.2017.08.011. Epub 2017 Sep 28.
4
Immunotherapy in allergic rhinitis and lower airway outcomes.变应性鼻炎和下呼吸道结局的免疫治疗。
Allergy. 2017 Jan;72(1):35-42. doi: 10.1111/all.12989. Epub 2016 Aug 15.
5
[ALLERGEN IMMUNOTHERAPY FOR ALLERGIC RHINITIS].[变应性鼻炎的变应原免疫治疗]
Arerugi. 2015 May;64(5):693-8; quiz 698-9.
6
Safety and efficacy of rush allergen-specific immunotherapy in Chinese allergic rhinitis patients.速发型变应原特异性免疫疗法在中国变应性鼻炎患者中的安全性和有效性。
Int J Immunopathol Pharmacol. 2016 Dec;29(4):720-725. doi: 10.1177/0394632016659301. Epub 2016 Aug 10.
7
Sublingual or subcutaneous immunotherapy for allergic rhinitis?舌下免疫治疗或皮下免疫治疗用于变应性鼻炎？
J Allergy Clin Immunol. 2016 Feb;137(2):339-349.e10. doi: 10.1016/j.jaci.2015.12.1298.
8
[Intralymphatic allergen-specific immunotherapy].[淋巴内过敏原特异性免疫疗法]
Ugeskr Laeger. 2018 May 28;180(22).
9
Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1-derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study.2 个月贝他过敏原特异性免疫治疗对变应性鼻结膜炎患者的疗效：一项 2b 期研究的结果。
J Allergy Clin Immunol. 2016 Jul;138(1):162-8. doi: 10.1016/j.jaci.2016.02.044. Epub 2016 May 6.
10
Inadequate knowledge of allergen immunotherapy among athletes with allergic rhinitis: A post hoc analysis.变应性鼻炎运动员对变应原免疫疗法的认知不足：一项事后分析。
Allergy. 2019 Dec;74(12):2508-2511. doi: 10.1111/all.13922. Epub 2019 Jun 24.
引用本文的文献
1
COVID-19 pandemic and allergen immunotherapy-an EAACI survey.COVID-19 大流行与变应原免疫治疗：一项 EAACI 调查。
Allergy. 2021 Nov;76(11):3504-3516. doi: 10.1111/all.14793. Epub 2021 Aug 25.
2
Mining social media data to assess the risk of skin and soft tissue infections from allergen immunotherapy.从变应原免疫治疗中挖掘社交媒体数据以评估皮肤和软组织感染的风险。
J Allergy Clin Immunol. 2019 Jul;144(1):129-134. doi: 10.1016/j.jaci.2019.01.029. Epub 2019 Feb 2.
本文引用的文献
1
Clinical practice. Allergic rhinitis.临床实践。变应性鼻炎。
N Engl J Med. 2015 Jan 29;372(5):456-63. doi: 10.1056/NEJMcp1412282.
2
Allergen immunotherapy: a practice parameter third update.变应原免疫疗法：实践参数第三次更新
J Allergy Clin Immunol. 2011 Jan;127(1 Suppl):S1-55. doi: 10.1016/j.jaci.2010.09.034. Epub 2010 Dec 3.
3
Epidemiology of dermatitis and skin infections in United States physicians' offices, 1993-2005.1993 - 2005年美国医生办公室中皮炎和皮肤感染的流行病学情况
Clin Infect Dis. 2009 Sep 15;49(6):901-7. doi: 10.1086/605434.
4
Monitoring bacteriostasis in allergen extract mixing: 10 years of culture data.变应原提取物混合中的抑菌监测：10年培养数据
J Allergy Clin Immunol. 2009 May;123(5):1175-6. doi: 10.1016/j.jaci.2009.01.048. Epub 2009 Feb 28.
5
Administrative coding data, compared with CDC/NHSN criteria, are poor indicators of health care-associated infections.与美国疾病控制与预防中心/国家医疗安全网络（CDC/NHSN）标准相比，行政编码数据对于医疗保健相关感染而言是较差的指标。
Am J Infect Control. 2008 Apr;36(3):155-64. doi: 10.1016/j.ajic.2008.01.004.
6
Allergic rhinitis.变应性鼻炎
Prim Care. 2008 Mar;35(1):1-10, v. doi: 10.1016/j.pop.2007.09.001.
7
Allergen vial mixing and immunotherapy: Risks of infections and vial contamination.变应原小瓶混合与免疫疗法：感染及小瓶污染风险
Otolaryngol Head Neck Surg. 2007 Aug;137(2):243-5. doi: 10.1016/j.otohns.2007.02.012.
Zotero 插件